.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
THURSDAY, April 3, 2025 -- There is a notable gap in public awareness and knowl...
THURSDAY, April 3, 2025 -- Use of hormonal contraceptives postpartum is associa...
THURSDAY, April 3, 2025 -- Use of the NeuroSAFE technique, a standardized froze...
THURSDAY, April 3, 2025 -- Early-life ozone (O3) exposure is associated with as...
THURSDAY, April 3, 2025 -- Zoster vaccination seems to have a dementia-preventi...
The government alleges UnitedHealth failed to return at least $2 billion in Medi...
Under the scheme, drugmakers discount the price of medicines sold in bulk to the...
At a chaotic time, the NIH is given a deadline of April 8 to make a 35% cut in s...
The California biotech will use the cash infusion to support its pipeline of all...
US consumers are likely to be hit by the price rises across sectors from aviatio...
Jim O’Neill, President Trump’s pick to be second in command at HHS, has a histor...
The U.K. is starting to recognize that the country needs to change how it pays f...
The president will impose a baseline 10% tariff on all countries, as well as hig...
Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, ...
In response to a request from the European Medicines Agency following the death ...
Camilla Sylvest is stepping down from her role as executive vice president, comm...
The Swiss drugmaker, which holds European rights to Elevidys, suspended three tr...
Human medicines European public assessment report (EPAR): Lutathera, lutetium (1...
The German conglomerate said the deal would not only add to its work in artifici...
Human medicines European public assessment report (EPAR): Ronapreve, casirivimab...
The FDA's approval for Novartis' atrasentan in the kidney disease IgAN means Chi...
Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, D...
US consumers are set to be the biggest victims with cost increases set to be pas...
As Nxera Pharma proceeds into the “next era” implied by its name—following a reb...